
Chlorthalidone (12.5mg) + Cilnidipine (10mg) + Telmisartan (40mg)
Active composition
+2 more active ingredients
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
**Introducing Cilnicaid-Trio Tablet: A Synergistic Solution for Effective Blood Pressure Management** Say goodbye to the complexities of managing blood pressure with Cilnicaid-Trio Tablet, a carefully crafted blend of Telmisartan (40mg), Cilnidipine (10mg), and Chlorthalidone (12.5mg). This innovative combination tablet is designed to provide comprehensive blood pressure control, reducing the need for separate medications and simplifying your treatment routine. The trio of ingredients works in harmony to effectively regulate blood pressure, promoting a healthier cardiovascular system. Telmisartan, a proven angiotensin II receptor blocker, helps to relax blood vessels and reduce pressure. Cilnidipine, a calcium channel blocker, further contributes to vasodilation and blood pressure reduction. Chlorthalidone, a diuretic, helps to remove excess fluid and sodium from the body, supporting overall cardiovascular health. With Cilnicaid-Trio Tablet, you can enjoy the benefits of effective blood pressure management, including reduced risk of cardiovascular events, stroke, and kidney disease. Simply take one tablet once daily, as directed, to experience the power of synergistic therapy. Experience the simplicity and effectiveness of Cilnicaid-Trio Tablet – your partner in maintaining a healthy blood pressure.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Cilnicaid-Trio Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Information regarding the use of Cilnicaid-Trio Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Cilnicaid-Trio Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Cilnicaid-Trio Tablet may be needed. Please consult your doctor. Use of Cilnicaid-Trio Tablet is not recommended in these patients.
Exercise Caution
Cilnicaid-Trio Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Cilnicaid-Trio Tablet should be used with caution in patients with liver disease. Dose adjustment of Cilnicaid-Trio Tablet may be needed. Please consult your doctor. Use of Cilnicaid-Trio Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Cilnicaid-Trio Tablet

Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Cilnidipine inhibits L-type and N-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced blood pressure.
Telmisartan selectively blocks angiotensin II receptors, leading to vasodilation and decreased blood pressure.
Medical applications
**Introducing Cilnicaid-Trio Tablet: A Synergistic Solution for Effective Blood Pressure Management** Say goodbye to the complexities of managing blood pressure with Cilnicaid-Trio Tablet, a carefully crafted blend of Telmisartan (40mg), Cilnidipine (10mg), and Chlorthalidone (12.5mg). This innovative combination tablet is designed to provide comprehensive blood pressure control, reducing the need for separate medications and simplifying your treatment routine. The trio of ingredients works in harmony to effectively regulate blood pressure, promoting a healthier cardiovascular system. Telmisartan, a proven angiotensin II receptor blocker, helps to relax blood vessels and reduce pressure. Cilnidipine, a calcium channel blocker, further contributes to vasodilation and blood pressure reduction. Chlorthalidone, a diuretic, helps to remove excess fluid and sodium from the body, supporting overall cardiovascular health. With Cilnicaid-Trio Tablet, you can enjoy the benefits of effective blood pressure management, including reduced risk of cardiovascular events, stroke, and kidney disease. Simply take one tablet once daily, as directed, to experience the power of synergistic therapy. Experience the simplicity and effectiveness of Cilnicaid-Trio Tablet – your partner in maintaining a healthy blood pressure.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Cilnicaid-Trio Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
High Risk
Information regarding the use of Cilnicaid-Trio Tablet during breastfeeding is not available. Please consult your doctor.
Medical Advice
Cilnicaid-Trio Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Cilnicaid-Trio Tablet may be needed. Please consult your doctor. Use of Cilnicaid-Trio Tablet is not recommended in these patients.
Exercise Caution
Cilnicaid-Trio Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Cilnicaid-Trio Tablet should be used with caution in patients with liver disease. Dose adjustment of Cilnicaid-Trio Tablet may be needed. Please consult your doctor. Use of Cilnicaid-Trio Tablet is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for Cilnicaid-Trio Tablet















